- psychiatry https://www.mcgill.ca/psychiatry
- med_fac http://www.mcgill.ca/channels
- In the Headlines
- mni https://www.mcgill.ca/channels-contribute
- Medicine Research
- medicine_research https://www.mcgill.ca/medicine
- press_releases https://www.mcgill.ca/newsroom
McGill University’s board of governors has adopted a resolution demanding the Quebec government withdraw the cuts it is imposing on universities and restore the funding that was in place, saying the government’s action is “excessive and injurious” to the university.
Message from Normand Rinfret, Director General and CEO
It is with great pleasure that we announce the appointment of Dr. Nadia Szkrumelak to the position of Chief of the Department of Psychiatry.
Dr. Szkrumelak is a graduate of McGill University, and has been a member of the Department of Psychiatry at the MUHC since 1984.
Prescription medications remain one of the most common causes of severe adverse reactions in clinical medicine, accounting for thousands of deaths annually in Canada. The urgent need for rigorous, scientific drug safety research has been clearly understood for decades, but lacked national coordination until the arrival of the Canadian Network for Observational Drug Effect Studies (CNODES), which today released its first report documenting progress towards its goal of creating a fully operational system for rapid assessment of adverse drug effects in Canada.
"Despite high per-capita spending, health care in Canada consistently underperforms, according to the Commonwealth Fund, which tracks indicators for accessibility, timeliness and outcomes across a number of developed countries. The system that is straining to meet demand today will face an even higher burden in the years ahead, as the population ages. A number of Canadian business schools are looking to meet this challenge by educating future health care managers to bring new perspectives to old problems.